Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CVS Health Corp (CVS)
NYSE:CVS
CVS Health (CVS) Stock Price & Analysis
11,776 Followers
CVS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$53.70 - $81.71
Previous Close$55.15
Volume16.87M
Average Volume (3M)10.75M
Market Cap
$72.07B
Enterprise Value$137.51B
Total Cash (Recent Filing)$11.46B
Total Debt (Recent Filing)$79.39B
Price to Earnings (P/E)9.7
Beta0.45
Next Earnings
Jul 31, 2024EPS Estimate
$1.94Last Dividend Ex-Date
Apr 19, 2024Dividend Yield4.61%
Share Statistics
EPS (TTM)5.69
Shares Outstanding1,255,372,972
10 Day Avg. Volume16,955,192
30 Day Avg. Volume10,746,881
Standard Deviation0.07
R-Squared0.17
Alpha0.00276
Financial Highlights & Ratios
Price to Book (P/B)-1.61
Price to Sales (P/S)0.74
Price to Cash Flow (P/CF)-6.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.42
Enterprise Value/Gross Profit0.98
Enterprise Value/Ebitda10.06
Forecast
1Y Price Target
$75.37Price Target Upside34.37% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering20
CVS Health News
PremiumMarket News
SPY ETF Update, 5/3/2024 
Bulls Say, Bears Say
Bulls Say
Cash Flow And ValuationAnalyst reiterates Outperform rating with continued strong cash flow supporting an overly-discounted stock.
Market Share GrowthCVS's pharmacy and consumer wellness segment is successfully gaining market share despite a challenging economic environment.
Ratings ImprovementThe improvement in Aetna's Stars ratings should translate to a significant boost in AOI.
Bears Say
Cost PressuresNotable cost pressures in outpatient services, inpatient care, RSV vaccines, and pharmacy.
Earnings GuidanceAnalyst downgrades CVS from Outperform to Market Perform and lowers the 12-month price target from $87 to $60 due to increased unknowns.
Medicare Advantage ChallengesThe lack of rate upside creates another decision tree that will determine the ability for CVS to execute on its updated 6% EPS growth targets.
---
Ownership Overview
0.91% Insiders
28.80% Mutual Funds
23.07% Other Institutional Investors
47.22% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Ability to SellRisks related to the company’s ability to sell goods and services
Website Traffic
The estimated number of people who visited one or more of the websites owned by CVS Health
Desktop Users
Mobile Users
CVS FAQ
What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest stock price was $53.70 and its highest was $81.71 in the past 12 months.
What is CVS Health Corp’s market cap?
Currently, no data Available
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is Jul 31, 2024 which is in 88 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on May 01, 2024. The company reported $1.31 earnings per share for the quarter, missing the consensus estimate of $1.695 by -$0.385.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp pays a Quarterly dividend of $0.67 which represents an annual dividend yield of 4.61%. See more information on CVS Health Corp dividends here
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is $1.94.
How many shares outstanding does CVS Health Corp have?
CVS Health Corp has 1,258,449,600 shares outstanding.
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of $1.31 in its last earnings report, missing expectations of $1.695. Following the earnings report the stock price went down -16.837%.
Which hedge fund is a major shareholder of CVS Health Corp?
Among the largest hedge funds holding CVS Health Corp’s share is Dodge & Cox. It holds CVS Health Corp’s shares valued at 2B.
---
CVS Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$75.37 (34.37% Upside)
$75.37 (34.37% Upside)
Blogger Sentiment
Bullish
CVS Sentiment 95%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 4.3M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.9%
Last 30 Days >0.1%
Last 30 Days >0.1%
News Sentiment
Very Bearish
Bullish news 17%
Bearish news 83%
Bearish news 83%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-21.47%
12-Months-Change
Fundamentals
Return on Equity
10.07%
Trailing 12-Months
Asset Growth
4.35%
Trailing 12-Months
Company Description
CVS Health Corp
Headquartered in Rhode Island and founded in 1963, CVS Health Corp. is a healthcare company in the U.S. that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands.
---
CVS Company Deck
---
CVS Earnings Call
Q1 2024
0:00 / 0:00
---
CVS Revenue Breakdown
52.22% Health Services
32.64% Pharmacy & Consumer Wellness
29.53% Health Care Benefits
0.13% Corporate/ Other
---
CVS Stock 12 Months Forecast
Average Price Target
$75.37
▲(34.37% Upside)
Technical Analysis
Best Analysts Covering CVS
1 Year
1 Year Success Rate
14/27 ratings generated profit
1 Year Average Return
+4.22%
reiterated a buy rating 2 days ago
Copying John Ransom's trades and holding each position for 1 Year would result in 51.85% of your transactions generating a profit, with an average return of +4.22% per trade.
---